Compare
Medline Inc. vs 3M Co vs Becton Dickinson & Co vs Baxter International Inc
| Latest fiscal year | Medline Inc. MDLN | 3M Co MMM | Becton Dickinson & Co BDX | Baxter International Inc BAX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-09-30 | 2025-12-31 |
| Revenue | $28.43B | $24.95B | $21.84B | $11.24B |
| Revenue growth (YoY) | +11.5% | +1.5% | +8.2% | +5.7% |
| Gross margin | 26.4% | 39.9% (computed) | 45.4% (computed) | 30.1% |
| Operating margin | 7.8% | 18.6% | 11.8% | -2.7% |
| Net margin | 4.1% | 13.0% | 7.7% | -8.5% |
| Net income | $1.16B | $3.25B | $1.68B | -$957.00M |
| EPS (Diluted) | -$0.01 | $6.00 | $5.82 | -$1.87 |
| Operating cash flow | $1.74B | $2.31B | $3.43B | $845.00M |
| Free cash flow | $1.30B | $1.40B | $2.67B | $332.00M |
| Cash & equivalents | $1.94B | n/a | $641.00M | $1.97B |
| Total assets | $38.48B | $37.73B | $55.33B | $20.05B |
| Total liabilities | $19.20B | $32.99B | n/a | $13.95B |
| Shareholders' equity | $10.74B | $4.75B | $25.39B | $6.10B |
| Return on year-end equity | 10.8% | 68.5% | 6.6% | -15.7% |
| Shares outstanding | n/a | 530.28M | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Medline Inc. | 3M Co | Becton Dickinson & Co | Baxter International Inc |
|---|---|---|---|---|
| Latest | $28.43B Ended 2025-12-31 | $24.95B Ended 2025-12-31 | $21.84B Ended 2025-09-30 | $11.24B Ended 2025-12-31 |
| 1 year earlier | $25.51B Ended 2024-12-31 | $24.57B Ended 2024-12-31 | $20.18B Ended 2024-09-30 | $10.64B Ended 2024-12-31 |
| 2 years earlier | $23.23B Ended 2023-12-31 | $24.61B Ended 2023-12-31 | $19.37B Ended 2023-09-30 | $10.36B Ended 2023-12-31 |
| 3 years earlier | n/a | $26.16B Ended 2022-12-31 | $18.87B Ended 2022-09-30 | $10.06B Ended 2022-12-31 |
| 4 years earlier | n/a | $35.35B Ended 2021-12-31 | $19.13B Ended 2021-09-30 | $12.15B Ended 2021-12-31 |